ALLMedicine™ Ventilator-associated Pneumonia Center

Feb 19th, 2021 - The COVID-19 pandemic is responsible for many hospitalizations in intensive care units (ICU), with widespread use of invasive mechanical ventilation (IMV) which exposes patients to the risk of ventilator-associated pneumonia (VAP). The characteris...

Feb 19th, 2021 - Although experimental evidence supports the use of nebulized antibiotics in ventilator-associated pneumonia (VAP), two recent multicenter randomized controlled trials (RCTs) have failed to demonstrate any benefit in VAP caused by Gram-negative bac...

Feb 17th, 2021 - Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired infections in ICUs and is associated with significant morbidity and mortality. Gram-negative bacteria cause 55-85% of hospital-acquired pneumonia and are associated ...

Feb 15th, 2021 - Ventilator-associated pneumonia (VAP) is a common cause of morbidity and mortality in intensive care unit (ICU), and among the several preventative strategies described to reduce the incidence of VAP, the most important is the endotracheal tube cu...

Feb 9th, 2021 - Carbapenemase-producing Klebsiella pneumoniae is an emerging threat worldwide. The appropriate therapy for infections due to these multidrug-resistant pathogens is not well defined and depends upon the susceptibilities of individual isolates, and ...

Sep 11th, 2017 - The most recent European guidelines and task force reports on hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 years ago. Since then, further randomised clinical trials of HAP and VAP have been c...

Jul 15th, 2016 - It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adher...

May 17th, 2016 - It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations.

Jul 15th, 2014 - Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.|2014|Klompas M,Branson R,Eichenwald EC,Greene LR,Howell MD,|standards,diagnosis,prevention & control,adverse effects,

Sep 27th, 2010 - The Association for Professionals in Infection Control and Epidemiology (APIC) began publishing their series of Elimination Guides in 2007. Since then, 9 Elimination Guides have been developed that cover a range of important infection prevention i...

Feb 19th, 2021 - The COVID-19 pandemic is responsible for many hospitalizations in intensive care units (ICU), with widespread use of invasive mechanical ventilation (IMV) which exposes patients to the risk of ventilator-associated pneumonia (VAP). The characteris...

Feb 19th, 2021 - Although experimental evidence supports the use of nebulized antibiotics in ventilator-associated pneumonia (VAP), two recent multicenter randomized controlled trials (RCTs) have failed to demonstrate any benefit in VAP caused by Gram-negative bac...

Feb 17th, 2021 - Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired infections in ICUs and is associated with significant morbidity and mortality. Gram-negative bacteria cause 55-85% of hospital-acquired pneumonia and are associated ...

Feb 15th, 2021 - Ventilator-associated pneumonia (VAP) is a common cause of morbidity and mortality in intensive care unit (ICU), and among the several preventative strategies described to reduce the incidence of VAP, the most important is the endotracheal tube cu...

Feb 9th, 2021 - Carbapenemase-producing Klebsiella pneumoniae is an emerging threat worldwide. The appropriate therapy for infections due to these multidrug-resistant pathogens is not well defined and depends upon the susceptibilities of individual isolates, and ...

Dec 11th, 2019 - The concept of healthcare-associated pneumonia (HCAP) gained widespread acceptance in 2005 after it was endorsed by an American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guideline. Since then, labeling patients with HCAP...

Nov 19th, 2019 - A 2-day course of prophylactic antibiotic therapy can lower the risk of early ventilator-associated pneumonia (VAP) in cardiac arrest patients, a new study suggests. Investigators compared administration of amoxicillin-clavulanate vs placebo in ad...

Apr 1st, 2019 - A 60-year-old man is admitted for respiratory failure following a massive myocardial infarction. He develops ventilator-associated pneumonia and is treated with cefepime and vancomycin.

Mar 8th, 2019 - SAN DIEGO – A rounding team formed to oversee implementation of a bundle of ICU interventions reduced the incidence of ventilator-associated pneumonia (VAP) and the number of ventilation days, as well as the ICU and hospital length of stay, accord.

Dec 6th, 2018 - In a large prospectively collected database, the risk of death at 30 days in ICU patients was far greater in those with hospital-acquired pneumonia (HAP) than in those with ventilator-associated pneumonia (VAP) even after adjustment for prognostic.